Raymond Chan retweetledi

Empagliflozin improves glycemia in individuals with HN1A-MODY (MODY3) – results from a randomized, crossover trial.
Read here ➡️ doi.org/10.2337/dc25-2…
@AmDiabetesAssn @ADA_DiabetesPro @ADA_Pubs

English
Raymond Chan
3 posts






A bit late but excited to have this on #EJPC! We showed that⬆️IL6 was a/w ⬆️eGFR decline, albuminuria, and CKD risk Thank you to my co-lead @ykjohnson07, amazing guidance from @DrMichaelShapir, & team (tags below) academic.oup.com/eurjpc/advance…